Synergistic effect of [10]-gingerol and aminoglycosides against vancomycin-resistant enterococci (VRE)

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 3, 2006, Pages 443-447

  Nagoshi, Chihiro ^a   Shiota, Sumiko ^a   Kuroda, Teruo ^a   Hatano, Tsutomu ^a   Yoshida, Takashi ^a   Kariyama, Reiko ^b   Tsuchiya, Tomofusa ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

Author keywords

10 gingerol; Aminoglycoside; Arbekacin; Vancomycin resistant enterococci (VRE)

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; BACITRACIN; BENZALKONIUM CHLORIDE; CHLORHEXIDINE GLUCONATE; DODECYL SULFATE; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; GINGER EXTRACT; GINGEROL; HABEKACIN; KANAMYCIN; NORFLOXACIN; POLYMYXIN B; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN; TRITON X 100; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG ISOLATION; DRUG POTENTIATION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GINGER; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ACETYLTRANSFERASES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CELL COUNT; COLONY COUNT, MICROBIAL; DETERGENTS; DIBEKACIN; DRUG SYNERGISM; ENTEROCOCCUS FAECALIS; FATTY ALCOHOLS; MICROBIAL SENSITIVITY TESTS; MUTAGENS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SODIUM DODECYL SULFATE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS; VANCOMYCIN RESISTANCE;

EID: 33645228768     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.443     Document Type: Article

References (18)

1. Murray B. E., New Engl. J. Med., 342, 710-721 (2000).
2. Kare I., Konstabel C., Badstubner D., Werner G., Witte W., Int. J. Food Microbiol., 88, 269-290 (2003).
3. Moellering R. C., Jr., Weinberg A. N., J. Clin. Investig., 50, 2580-2584 (1971).
4. Huycke M. M., Sahm D. F., Gilmore M. S., Emerging Infect. Dis., 4, 239-249 (1998).
5. Sahm D. F., Marsilio M. K., Piazza G., Clin. Infect. Dis., 29, 259-263 (1999).
6. Tsai S. F., Zervos M. J., Clewell D. B., Donabedian S. M., Sahm D. F., Chow J. W., Antimicrob. Agents Chemother., 42, 1229-1232 (1998).
7. Boehr D. D., Lane W. S., Wright G. D., Chem. Biol., 8, 791-800 (2001).
8. Daigle D. M., McKay G. A., Wright G. D., J. Biol. Chem., 272, 24755-24758 (1997).
9. Kak V., Donabedian S. M., Zervos M. J., Kariyama R., Kumon H., Chow J. W., Antimicrob. Agents Chemother., 44, 2545-2546 (2000).
10. Kak V., You I., Zervos M. J., Kariyama R., Kumon H., Chow J. W., Diagn. Microbiol. Infect. Dis., 37, 297-299 (2000).
11. Kariyama R., Kumon H., Chow L., Zervos M. J., Takata T., Tabata M., Chow J. W., J. Antimicrob. Chemother., 42, 836-838 (1998).
12. Shiota S., Shimizu M., Mizushima T., Ito H., Hatano T., Yoshida T., Tsuchiya T., FEMS Microb. Lett., 185, 135-138 (2000).
13. Eliopoulos G. M., Moellering R. C., "Antibiotics in Laboratory Medicine," 3rd ed., ed. by Loorian V., Williams and Wilkins, Baltimore, MD, 1991.
14. Shiota S., Shimizu M., Mizushima T., Ito H., Hatano T., Yoshida T., Tsuchiya T., Biol. Pharm. Bull., 22, 1388-1390 (1999).
15. Shimizu M., Shiota S., Mizushima T., Ito H., Hatano T., Yoshida T., Tsuchiya T., Antimicrob. Agents Chemother., 45, 3198-3201 (2001).
16. Shiota S., Shimizu M., Sugiyama J., Morita Y., Mizushima T., Tsuchiya T., Microbiol. Immunol., 48, 67-73 (2004).
17. Fujita M., Shiota S., Kuroda T., Mizushima T., Hatano T., Yoshida T., Tsuchiya T., Microbiol. Immunol., 49, 391-396 (2005).
18. Nakamura H., Yamamoto T., Mutat. Res., 122, 87-94 (1983).